Narcis Tablets

Narcis Tablets

$144.94

Brand: Category Use Cases: , Form:

Narcis Tablets is offered in 2 variants: 25mg Cardarine, 13mg YK-11 and 25mg MK677, totaling 63mg per tablet for 20 tablets or 1250mg in total; and 25mg Cardarine, 13mg YK-11 and 25mg MK677, totaling 63mg per tablet for 40 tablets or 2500mg in total.

The study showed that mice with low levels of myostatin had twice the amount of muscle mass compared to mice with high levels of myostatin. This demonstrates the potential implications of the strong anabolic effects that YK-11 can possess. GW-501516, also known as Cardarine, is a PPAR agonist that has been found to increase endurance and stamina in mice. A study on the effects of MK-677 as a Ghrelin mimetic on body composition and clinical outcomes in healthy older adults found that MK-677 increased fat free mass over a 12-month period.

YK-11
CAS Number 1370003-76-1
Molar Mass 430.541 g·mol−1
Chemical Formula C25H34O6
IUPAC Name methyl (2E)-2-[(8R,9S,10R,13S,14S,17S)-2′-methoxy-2′,13-dimethyl-3-oxospiro[1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-17,5′-1,3-dioxolane]-4′-ylidene]acetate
Cardarine
CAS Number 317318-70-0
Molar Mass 453.49 g·mol−1
Chemical Formula C21H18F3NO3S2
IUPAC Name 4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid
MK677
CAS Number 159634-47-6
Molar Mass 528.67 g·mol−1
Chemical Formula C14H12F6N2O
IUPAC Name 2-amino-2-methyl-N-[1-(1-methylsulfonylspiro[2H indole-3,4′-piperidine]-1′-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propenamide

Buy Now

onpeptides.com participates in the Amazon Associates Associates Program, an affiliate advertising program designed to provide a means for sites to earn commissions by linking to Amazon. This means that whenever you buy a product on Amazon from a link on here, we get a small percentage of its price.

onpeptides.com does not offer medical diagnosis or treatment advice we make no claims that the products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.

This information has not been evaluated by the Food and Drug Administration (FDA).
onpeptides.com